Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health...
from NDTV News - Special https://ift.tt/3lXILh9
via
No comments:
Post a Comment